{
  "id": 10696499,
  "title": "After GLP-1s, biosimilars are the new frontier in direct-to-employer plans",
  "url": "https://urgent.news/2026/09/29/after-glp-1s-biosimilars-are-the-new-frontier-in-direct-to-employer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-29T13:00:58.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/after-glp-1s-biosimilars-are-the-new-frontier-in-direct-to-employer-plans/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Fresenius Kabi will sell biosimilars directly to employers. To accomplish that, the drugmaker is working with Eversana-owned Waltz Health, which runs a marketplace that helps employers shop for better deals on prescription ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}